Bio Business
Subjects
Most Recent
Treating Fat with Fat
By Edyta Zielinska | May 1, 2012
Is brown fat ready for therapeutic prime time?
Braving the IPO Drought
By Megan Scudellari | March 1, 2012
Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.
Bioterrorist Battles
By Fran Hawthorne | January 1, 2012
A Swiss-based firm may have a back-door way to thwart a bioterrorist attack—by fighting the flu.
New Tech Boosts Science
By Tia Ghose | October 1, 2011
From iPhone apps to cloud computing, everyday digital technologies are helping advance drug discovery, conduct clinical trials, and improve medical care.
Make Mine Rare
By Megan Scudellari | August 1, 2011
With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.
Take Two of These
By Bob Grant | May 27, 2011
Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.
Teaching an Old Drug New Tricks
By Megan Scudellari | April 1, 2011
Biotech companies hope to turn the practice of finding novel uses for existing compounds into big business.
Alternative Agriculture
By Vanessa Schipani | February 1, 2011
The debate over genetically engineered crops rages on, but other technologies offer new hope for sustainable farming.
The Profits of Nonprofit
By Megan Scudellari | January 1, 2011
The surprising results when drug development and altruism collide
